ALLISON LONG: Open Payments
NPI 1578048872 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 111 payments from 17 companies in 2025. Trend: 2023 $2,493 · 2024 $2,686 · 2025 $1,868
Food & beverage: $1,868
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $736 |
| Janssen Biotech, Inc. | 17 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $138 |
| QOL Medical, LLC | 5 | $119 |
| Gilead Sciences, Inc. | 5 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $97 |
| Ardelyx, Inc. | 4 | $65 |
| Madrigal Pharmaceuticals | 3 | $56 |
| GENZYME CORPORATION | 2 | $54 |
| Enterra Medical, Inc. | 1 | $52 |
Products named: RINVOQ, TREMFYA, Linzess, Sucraid, ENTYVIO, XIFAXAN, SKYRIZI, CREON.
Industry payments across GA — which companies pay providers there.
